论文信息 - Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides - 字舞流文

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides

L. Mariani | V. Chiarion-Sileni | M. Maio | A. Villa | C. Lombardo | G. Parmiani | A. Maurichi | M. Santinami | R. Danielli | C. Castelli | L. Rivoltini | R. Patuzzo | G. Tragni | P. Frati | C. Camisaschi | P. Filipazzi | A. Cova | P. Squarcina | L. Pilla | Gloria Sovena | G. Rigamonti | M. Asioli | F. Giardino | Annabella Di Florio